KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Common Equity (2016 - 2025)

Precigen (PGEN) has disclosed Common Equity for 15 consecutive years, with $20.9 million as the latest value for Q4 2025.

  • Quarterly Common Equity fell 45.7% to $20.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.9 million through Dec 2025, down 45.7% year-over-year, with the annual reading at $20.9 million for FY2025, 45.7% down from the prior year.
  • Common Equity for Q4 2025 was $20.9 million at Precigen, down from $41.9 million in the prior quarter.
  • The five-year high for Common Equity was $184.1 million in Q1 2023, with the low at -$36.8 million in Q2 2025.
  • Average Common Equity over 5 years is $91.7 million, with a median of $102.2 million recorded in 2021.
  • The sharpest move saw Common Equity surged 221.34% in 2021, then tumbled 185.2% in 2025.
  • Over 5 years, Common Equity stood at $107.3 million in 2021, then rose by 17.62% to $126.3 million in 2022, then fell by 6.15% to $118.5 million in 2023, then tumbled by 67.5% to $38.5 million in 2024, then crashed by 45.7% to $20.9 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $20.9 million, $41.9 million, and -$36.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.